| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Lyell Immunopharma, Inc. (LYEL) have been net sellers, shedding 14,188 shares worth roughly $215K on balance. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
The insider who sold still holds shares after the sale. LYEL sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.77M | - | - | |
| 10% | 1.43M | $36.53M | - | |
| 10% | 1.43M | $36.53M | - | |
| CEO | 63.9K | $993.0K | - | |
| Other | 20.4K | $259.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | Aguirre Jarrad Mattieu | Chief Medical Officer | Sell | 422 | $8.63 | $3,641.86 | -2.1% | - | - | |
| Sep 10, 2026 | Shook David53 | Chief Medical Officer | Sell | 500 | $12.70 | $6,350.00 | -2.4% | - | - | |
| Aug 21, 2026 | Seely Lynn74 | President and CEO | Sell | 9,589 | $15.54 | $149,013.06 | -13.0% | - | - | |
| Aug 21, 2026 | Lee Gary K. | Chief Scientific Officer | Sell | 1,457 | $15.54 | $22,641.78 | -8.2% | - | - | |
| Aug 21, 2026 | Hill Stephen J. | Chief Operating Officer | Sell | 989 | $15.54 | $15,369.06 | -5.6% | - | - | |
| Aug 10, 2026 | Hill Stephen J. | Chief Operating Officer | Sell | 89 | $14.34 | $1,276.26 | -0.5% | - | - | |
| Aug 10, 2026 | Seely Lynn74 | President and CEO | Sell | 390 | $14.34 | $5,592.60 | -0.5% | - | - | |
| Aug 10, 2026 | Lee Gary K. | Chief Scientific Officer | Sell | 131 | $14.34 | $1,878.54 | -0.7% | - | - | |
| Aug 10, 2026 | Bulis Veronica Sanchez54 | VP, Corporate Controller | Sell | 621 | $14.34 | $8,905.14 | -4.0% | - | - | |
| Jul 17, 2026 | Innovative Cellular Therapeutics Holdings Ltd | 10% Owner | Sell10b5-1 | 10 | $13.70 | $137.00 | - | -38.5% | - |